• 1
    Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925-1932.
  • 2
    Sehested TS, Hansen TW, Olsen MH, et al. Measures of overweight and obesity and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil 2010; 17: 486-490.
  • 3
    Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
  • 4
    Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 2006; 27: 96-106.
  • 5
    de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28: 850-856.
  • 6
    Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring JE, Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 2008; 52: 605-615.
  • 7
    Dhaliwal SS, Welborn TA. Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores. Am J Cardiol 2009; 103: 1403-1407.
  • 8
    Wormser D, Kaptoge S, Di Angelantonio E, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085-1095.
  • 9
    Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666-678.
  • 10
    Galal W, van Domburg RT, Feringa HH, et al. Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol 2007; 99: 1485-1490.
  • 11
    Lee SH, Park JS, Kim W, et al. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol 2008; 102: 957-965.
  • 12
    Coutinho T, Goel K, Correa de Sa D, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011; 57: 1877-1886.
  • 13
    Dallongeville J, Bhatt DL, Steg PH, et al. Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol 2011; 19: 241-249.
  • 14
    Ikeda N, Nakajima R, Utsunomiya M, et al. Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels 2011; 26: 495-501.
  • 15
    Fonarow GC. The relationship between body mass index and mortality in patients hospitalized with acute decompensated heart failure. Am Heart J 2007; 154: e21.
  • 16
    Frankenstein L, Zugck C, Nelles M, Schellberg D, Katus HA, Remppis BA. The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders. Eur J Heart Fail 2009; 11: 1189-1194.
  • 17
    von Haehling S, Doehner W, Anker SD. Revisiting the obesity paradox in heart failure: new insights? Eur J Heart Fail 2011; 13: 130-132.
  • 18
    Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39: 578-584.
  • 19
    Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010; 31: 222-226.
  • 20
    Lancefield T, Clark DJ, Andrianopoulos N, et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv 2010; 3: 660-668.
  • 21
    Rubinshtein R, Halon DA, Jaffe R, Shahla J, Lewis BS. Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 2006; 97: 1277-1280.
  • 22
    Niraj A, Pradhan J, Fakhry H, Veeranna V, Afonso L. Severity of coronary artery disease in obese patients undergoing coronary angiography: “obesity paradox” revisited. Clin Cardiol 2007; 30: 391-396.
  • 23
    Phillips SD, Roberts WC. Comparison of body mass index among patients with versus without angiographic coronary artery disease. Am J Cardiol 2007; 100: 18-22.
  • 24
    Hodgson JM, Wahlqvist ML, Balazs ND, Boxall JA. Coronary atherosclerosis in relation to body fatness and its distribution. Int J Obes Relat Metab Disord 1994; 18: 41-46.
  • 25
    Rossi R, Iaccarino D, Nuzzo A, et al. Influence of body mass index on extent of coronary atherosclerosis and cardiac events in a cohort of patients at risk of coronary artery disease. Nutr Metab Cardiovasc Dis 2011; 21: 86-93.
  • 26
    Balkau B, Deanfield JE, Despres JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007; 116: 1942-1951.
  • 27
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
  • 28
    Ross R, Berentzen T, Bradshaw AJ, et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev 2008; 9: 312-325.
  • 29
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843.
  • 30
    Johnson NP, Wu E, Bonow RO, Holly TA. Relation of exercise capacity and body mass index to mortality in patients with intermediate to high risk of coronary artery disease. Am J Cardiol 2008; 102: 1028-1033.
  • 31
    Habbu A, Lakkis NM, Dokainish H. The obesity paradox: fact or fiction? Am J Cardiol 2006; 98: 944-948.
  • 32
    Clark AL, Fonarow GC, Horwich TB Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 2011; 17: 374-380.
  • 33
    Morricone L, Donati C, Hassan T, Cioffi P, Caviezel F. Relationship of visceral fat distribution to angiographically assessed coronary artery disease: results in subjects with or without diabetes or impaired glucose tolerance. Nutr Metab Cardiovasc Dis 2002; 12: 275-283.
  • 34
    Ohashi N, Yamamoto H, Horiguchi J, et al. Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. JACC Cardiovasc Imaging 2010; 3: 908-917.
  • 35
    Khashper A, Gaspar T, Azencot M, et al. Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics. Int J Cardiol 2013; 162: 184-188.
  • 36
    Berentzen TL, Angquist L, Kotronen A, et al. Waist circumference adjusted for body mass index and intra-abdominal fat mass. PLoS One 2012; 7: e32213
  • 37
    Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010; 362: 886-895.
  • 38
    Al Suwaidi J, Higano ST, Hamasaki S, Holmes DR, Lerman A. Association between obesity and coronary atherosclerosis and vascular remodeling. Am J Cardiol 2001; 88: 1300-1303.
  • 39
    Lee BC, Lee WJ, Hsu HC, Chien KL, Shih TT, Chen MF Using clinical cardiovascular risk scores to predict coronary artery plaque severity and stenosis detected by CT coronary angiography in asymptomatic Chinese subjects. Int J Cardiovasc Imaging 2011; 27: 669-678.
  • 40
    Versteylen MO, Joosen IA, Shaw LJ, Narula J, Hofstra L. Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol 2011; 18: 904-911.